Voice Prosthesis Devices Market Size & Share 2026-2035

Voice Prosthesis Devices Market Size

The global voice prosthesis devices market was estimated at USD 688.7 million in 2025. The market is expected to grow from USD 744 million in 2026 to USD 1.2 billion in 2035, at a CAGR of 5.4% during the forecast period, according to the latest report published by Global Market Insights Inc.

The market is driven by numerous factors such as increasing prevalence of laryngeal cancer, growing awareness about voice rehabilitation, expansion of ENT specialty clinics, and technological advancements in voice prosthesis devices, among other factors.

A rising geriatric population, growing availability of reimbursement for prosthetic devices and expansion into emerging markets are expected to fuel the industry's growth. Atos Medical (Coloplast), Andreas Fahl Medizintechnik-Vertrieb, InHealth Technologies, Servona GmbH, and Luminaud, Inc. are among the leading players operating in the market. These players mainly focus on product innovation, geographic expansion, research on advanced materials, integration of AI in devices, and collaboration with local or regional healthcare providers, among other factors.

The market has increased from USD 521.9 million in 2022 and reached USD 632.9 million in 2024, with a historic growth rate of 10.1%. Laryngeal cancer is one of the leading indications for laryngectomy, a surgical procedure involving the partial or total removal of the larynx. As the incidence of laryngeal cancer rises globally due to factors such as tobacco use, alcohol consumption, and human papillomavirus (HPV) infection, the demand for voice prosthesis devices also increases. Voice prosthesis devices play a crucial role in restoring speech function for patients who have undergone laryngectomy, driving market growth.

Furthermore, increasing awareness about voice prosthesis devices among patients, caregivers, and healthcare professionals drives market growth. Education programs, patient advocacy initiatives, and support groups play a crucial role in raising awareness about voice restoration options and encouraging their adoption. Healthcare providers are increasingly recognizing the importance of voice rehabilitation and referring patients for evaluation and treatment with voice prosthesis devices, thereby contributing to the market growth.

Voice prosthesis devices are medical implants used to restore speech in people who have undergone a total laryngectomy (surgical removal of the voice box). During the procedure, a surgeon creates a small opening between the trachea (windpipe) and esophagus called a tracheoesophageal puncture (TEP). A voice prosthesis is placed in this opening to act as a one‑way valve.

Voice Prosthesis Devices Market Trends

The voice prosthesis devices industry is experiencing several notable trends that are shaping its growth and development. Factors such as technological innovation in voice prosthesis devices, growing demand for non-indwelling prostheses, rising emphasis on personalized medicine and patient-centric solutions, and a surging need for minimally invasive surgical instruments & techniques, among other factors, are propelling the industry growth.

• Further, there is a growing demand for minimally invasive surgical techniques for laryngectomy, such as transoral laser microsurgery (TLM) and robotic-assisted surgery. Minimally invasive approaches minimize surgical trauma, reduce postoperative complications, and accelerate patient recovery, making them increasingly preferred options for voice restoration with prosthesis devices. The adoption of minimally invasive procedures expands patient access to voice rehabilitation and drives market growth.
• Moreover, the integration of voice prosthesis devices with digital health solutions, including mobile applications, wearable medical devices, and telemedicine platforms, enhances patient engagement, adherence, and monitoring. Digital health solutions enable remote communication with healthcare providers, access to educational resources, and real-time feedback on device performance. The integration of digital health solutions improves patient outcomes, reduces healthcare costs, and drives market growth for voice prosthesis devices.

Voice Prosthesis Devices Market Analysis

Based on product, the voice prosthesis devices market is segmented into indwelling voice prosthesis and non-indwelling voice prosthesis. The indwelling voice prosthesis segment accounted for a majority share of 66.4% in 2025. Growing number of total laryngectomy procedures is anticipated to fuel the segmental growth. The segment is expected to reach USD 780.8 million by 2035, growing at a CAGR of 5.2% during the forecast period.

• Indwelling voice prosthesis devices are designed to facilitate the production of natural and intelligible speech by restoring airflow between the trachea and the esophagus. These devices allow patients to articulate speech through the esophagus, resulting in improved speech quality, resonance, and articulation compared to alternative methods such as electrolarynx devices or esophageal speech. The ability to produce clear and natural speech enhances communication, social interaction, and overall quality of life for patients undergoing laryngectomy.
• Additionally, these devices are intended for long-term use and offer durable solutions for voice restoration following laryngectomy. These devices are typically made of biocompatible materials such as silicone and are designed to withstand the physiological stresses of daily speech production and swallowing.
• Further, the long-term durability of indwelling voice prosthesis devices reduces the need for frequent replacements and enhances patient satisfaction with the device. This is expected to boost the segmental growth in the market positively.
• The non-indwelling voice prosthesis segment is anticipated to record the higher growth, with a CAGR of 5.6%, to reach over USD 411 million by 2035. Non‑indwelling voice prostheses are patient‑managed devices for those who want to manage their own prosthesis, therefore giving them greater independence and the ability to remove and clean the prosthesis whenever they feel.
• Furthermore, they offer flexibility for patients living far from ENT centers or those who prefer hands‑on management of their rehabilitation.

Based on valve type, the voice prosthesis devices market is segmented into Provox valve, Blom-singer valve, and groningen valve. The Provox valve segment generated the highest revenue of USD 409.4 million in 2025.

• The Provox valve has demonstrated clinical efficacy and safety in restoring speech function for patients who have undergone total laryngectomy. Clinical studies and real-world evidence support the effectiveness of the Provox valve in facilitating natural and intelligible speech production, improving voice quality, and enhancing patient communication outcomes. The proven clinical efficacy of the Provox valve instills confidence among healthcare providers and patients, driving its adoption in clinical practice.
• Further, the Provox valve is available in various sizes, configurations, and options to accommodate individual patient anatomies, clinical preferences, and treatment goals. Healthcare providers can select the appropriate Provox valve size and fit based on patient characteristics such as tracheoesophageal puncture size, tissue elasticity, and surgical technique.
• Moreover, the customization and adaptability of the Provox valve optimize device performance, patient comfort, and speech outcomes, driving its adoption in diverse patient populations.
• The Blom-Singer valve segment is anticipated to record the highest growth, with a CAGR of 5.7%, to reach over USD 374 million by 2035. Blom-Singer valve products have a well-established clinical history and are available in both indwelling and non-indwelling designs, allowing for individualized treatment options to meet the needs of different patient populations.
• Additionally, these products are designed for stable airflow and easy manipulation and provide smooth voicing along with reliable one-way valve function. Many of the valves allow for patient-managed care so that the user is able to self-clean, self-replace, and/or self-adjust the device.
• In addition, the valves have a number of customization options to fit different anatomical shapes. The extensive use of Blom-Singer valves by the ENT community and the familiarity of the practitioners with them create a high level of confidence in their safety and efficacy for speech rehabilitation following a total laryngectomy.

Based on end use, the voice prosthesis devices market is segmented into hospitals, ENT clinics, and other end-users. The hospitals segment accounted for the leading market share of 60.1% in 2025.

• Hospitals encounter a growing number of patients diagnosed with laryngeal cancer, a leading indication for laryngectomy and voice restoration with prosthesis devices. The rising incidence of laryngeal cancer contributes to the demand for voice prosthesis devices within hospitals, as they are often the primary settings for cancer treatment, surgical interventions, and postoperative care.
• Additionally, hospitals possess advanced diagnostic imaging technologies, surgical facilities, and multidisciplinary teams of healthcare professionals capable of diagnosing and treating laryngeal disorders effectively.
• Further, specialized departments such as otolaryngology (ENT), head and neck surgery, and oncology offer comprehensive evaluation, surgical expertise, and rehabilitation services for patients undergoing laryngectomy and voice restoration with prosthesis devices, thereby fostering segmental growth in the market.
• The ENT clinics segment was valued at USD 162.5 million in 2025. Patients who require ongoing monitoring with voice prosthesis devices rely on a variety of services provided by ENT clinics as they help provide routine examinations of the voice prosthesis along with cleaning and inspection of the device. They also provide the replacement as needed of the device, as well as customized speech rehabilitation using the prosthesis.
• In addition, the ENT specialists in these clinics assist patients in resolving issues they may face with voice changes, leakage, or anatomical concerns with the tracheoesophageal puncture.
• These clinics are often much more accessible and convenient to patients than overall hospitals, allowing patients to have checkups frequently without long wait times.
• Furthermore, ENT clinics play a significant role in continued rehabilitation support for patients who use non-indwelling prosthesis devices on how to properly handle their device.

North America Voice Prosthesis Devices Market

The North America voice prosthesis devices industry accounted for a majority share of 42.5% in 2025 and is anticipated to show notable growth over the forecast period.

• The U.S. market was valued at USD 207.1 million and USD 229.3 million in 2022 and 2023, respectively. In 2025 the market size was valued at USD 271.6 million from USD 250.1 million in 2024.
• North America experiences a relatively high incidence of laryngeal cancer compared to other regions worldwide. Factors such as tobacco use, alcohol consumption, and human papillomavirus (HPV) infection contribute to the prevalence of laryngeal cancer in the region. The high incidence of laryngeal cancer drives the demand for voice prosthesis devices as a key treatment modality for patients undergoing laryngectomy and voice restoration.
• The region boasts advanced healthcare infrastructure, including state-of-the-art hospitals, specialized treatment centers, and academic medical institutions. The region's healthcare system offers access to advanced diagnostic technologies, surgical expertise, and rehabilitation services for patients with laryngeal disorders.
• Furthermore, the availability of advanced healthcare facilities and multidisciplinary care teams facilitates timely diagnosis, treatment, and rehabilitation with voice prosthesis devices.

Europe Voice Prosthesis Devices Market

Europe accounted for a significant share of the voice prosthesis devices industry and was valued at USD 194.6 million in 2025.

• Europe is expected to record steady growth in the voice prosthetic device market owing to its developed ENT care system, high quality of clinical practice, and widespread availability to provide laryngectomy rehabilitation services.
• Additionally, many European countries focus substantially on early detection of cancer along with treatment and rehabilitation of patients, which leads to more patients getting timely access to voice restoration services.
• Further, the emphasis placed by regulatory agencies on device performance and patient safety encourages innovation and gives Europe a leading edge over other regions in the adoption of products for voice rehabilitation.

Asia Pacific Voice Prosthesis Devices Market

The Asia Pacific voice prosthesis devices industry accounted for a substantial share of the market and was valued at USD 147 million in 2025.

• The Asia Pacific region is rapidly growing in market opportunities due to the increase of cancer, improving access to health care, and growing awareness for rehabilitation of voice after laryngectomy.
• Additionally, developments in surgical capability in China, India, South Korea, and Southeast Asian countries now allow more individuals to have laryngectomy surgery along with follow-up care. In addition, ENT specialty centers and better training for speech-language pathologists may further support the use of these devices in the area.
• Furthermore, as awareness improves, more patients seek prosthetic‑based voice restoration instead of traditional alternatives.

Latin America Voice Prosthesis Devices Market

The Latin American voice prosthesis devices industry is anticipated to exhibit remarkable growth during the analysis period.

• There is gradual market growth in Latin America owing to the rise in the number of cancer treatment facilities, along with the number of trained ENT specialists for tracheoesophageal voice restoration.
• Many urban hospitals in Brazil, Mexico, and Argentina are now utilizing more advanced prostheses for voice restoration as awareness concerning quality-of-life rehabilitation increases.
• Furthermore, the continued access for patients who require postoperative speech rehabilitation and the trend of healthcare systems prioritizing survivorship care may drive an increased demand for modern voice prosthesis devices.

Middle East and Africa Voice Prosthesis Devices Market

The Middle East and Africa voice prosthesis devices industry is expected to experience substantial growth over the analysis timeframe.

• The MEA region is witnessing gradual growth driven by expanding oncology services, rising healthcare investments, and increasing attention to quality‑of‑life outcomes after major surgeries.
• In Gulf countries, access to advanced ENT technologies and specialized surgeons supports higher adoption of voice prostheses.
• Further, as ENT capacity strengthens and more patients are directed toward structured rehabilitation pathways, market growth is expected to accelerate.

Voice Prosthesis Devices Market Share

The worldwide voice prosthetic devices market is consolidated in nature based on product durability, ease of insertion, long-term voice quality, and clinician knowledge about the product. Key players operating in the market include Atos Medical (Coloplast), Andreas Fahl Medizintechnik-Vertrieb, InHealth Technologies, Servona GmbH, Luminaud, Inc., and Innaumation Medical Devices, among others. With its extensive Provox product portfolio, service, education, and rehabilitation network, Atos Medical has become a market leader because of its ability to manufacture durable products, conduct effective training for clinicians, and have an established support system. Its customer‑support‑driven model and global distribution make it a benchmark for quality and reliability.

Additionally, InHealth Technologies continues to be a strong rival through the global usage of their Blom-Singer prosthesis line. They are well integrated into ENT surgical centers and have built an extensive clinical history based on high trust with surgeons, giving them a strong hold in key markets such as North America.

Similarly, Andreas Fahl Medizintechnik-Vertrieb GmbH has been able to compete via customization, precise engineering, and a broad selection of custom accessory lines designed specifically for providers in Europe. The company has created innovative solutions for clinicians that have unique anatomical issues by providing specialized and customized rehabilitation products.

Overall, the development and launch of novel advanced products based on different technologies is among the key market strategies propelling the product demand over the forecast timeframe.

Voice Prosthesis Devices Market Companies

A few of the prominent players operating in the voice prosthesis devices industry include:

• Andreas Fahl Medizintechnik-Vertrieb
• Atos Medical (Coloplast)
• HEIMOMED Heinze GmbH
• Hood Laboratories
• ICU Medical, Inc.
• InHealth Technologies
• Innaumation Medical Devices
• Luminaud, Inc.
• Servona GmbH
• Teleflex Incorporated

• Atos Medical (Coloplast)

Prioritize innovation in indwelling prostheses, enhance patient‑centric care pathways, expand global rehabilitation support networks, and integrate digital assistance tools to improve postoperative outcomes and strengthen brand loyalty worldwide.

• Andreas Fahl Medizintechnik-Vertrieb

Focus on precision‑engineered voice rehabilitation products, expand custom prosthesis solutions, strengthen clinician training programs, and grow international distribution through partnerships emphasizing reliability, patient comfort, and long‑term device performance.

Voice Prosthesis Devices Industry News

• In November 2025, Laronix, a commercial-stage medical technology company operating in the voice restoration technologies, announced that it had been awarded USD 2.1 million (approximately AUD 3.2 million) in non-dilutive funding from the Australian Government's Industry Growth Program (IGP 2025). The company's first product, AVA Voice, is commercially available in the U.S. and Australia. This development will enable the company to expand its reach in other key markets globally.
• In August 2022, InHealth Technologies announced the launch of Blom-Singer in the U.S. This unique device is designed for those who have had a complete laryngectomy. This innovative single-use heat and moisture exchange (HME) is compatible with the complete line of InHealth products and is comfortable to wear day or night, even before going to bed.

The voice prosthesis devices market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Indwelling voice prosthesis
• Non-indwelling voice prosthesis

Market, By Valve Type

• Provox valve
• Blom-singer valve
• Groningen valve

Market, By End Use

• Hospitals
• ENT clinics
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE